Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2013


9th Imaging in Cancer Drug Development

13 Mar 2013 - 14 Mar 2013 - London, UK



Bookmark and Share


Join SMI at the anticipated 9th annual Imaging in Cancer Drug Development conference in March 2013 that will be the ultimate opportunity to witness presentations on the current developments surrounding oncology, pre-clinical & clinical imaging, technical innovations and advancements, imaging biomarkers in cancer drug development and the future of imaging. 

With a reputation for attracting the industry’s leading figures, this year's agenda offers an unmatched opportunity for debate and resolution of key challenges and current advances in oncology imaging. 

KEY TOPICS FOR 2013 INCLUDE:

Latest developments in fluorescence and bioluminescence for drug monitoring in xenografts

Novel target identification and lead discovery in preclinical biomarkers and radiochemistry

Strengths and limitations of whole body optical imaging with X-ray micro CT and multiphoton intravital microscopy

Overcoming challenges in nuclear tracers for multiscale imaging in oncology

Current application of PET/SPET modalities and a review of PFS (progression-free survival)

Practical tools for business expansion in the current economic climate

For more information visit http://www.smi-online.co.uk/goto/cancer-imaging5.asp

Or contact Cem Tuna on tel +44 0 207 827 6736 or email ctuna@smi-online.co.uk 



Further information
Scientific News
Health Risks of Saturated Fats Aggravated by Immune Response
Research shows that the presence of saturated fats resulted in monocytes migrating into the tissues of vital organs.
Changing the Biological Data Visualisation World
Scientists at TGAC, alongside European partners, have created a cutting-edge, open source community for the life sciences.
NIH Study Finds Calorie Restriction Lowers Some Risk Factors for Age-Related Diseases
Two-year trial did not produce expected metabolic changes, but influenced other life span markers.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!